| scholarly article | Q13442814 |
| P50 | author | Ruth Lopert | Q57005902 |
| Peter B. McIntyre | Q68878852 | ||
| Julie E Bines | Q88189118 | ||
| Jim Buttery | Q105095703 | ||
| P2093 | author name string | John B Carlin | |
| Katherine J Lee | |||
| Helen E Quinn | |||
| Kristine K Macartney | |||
| P2860 | cites work | Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil | Q58232513 |
| Global burden of childhood pneumonia and diarrhoea | Q28288886 | ||
| Paediatric active enhanced disease surveillance: a new surveillance system for Australia. | Q30432122 | ||
| Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation | Q30540815 | ||
| Tutorial in biostatistics: the self-controlled case series method | Q33368891 | ||
| Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states | Q33558901 | ||
| Effect of rotavirus vaccination on death from childhood diarrhea in Mexico | Q34095180 | ||
| 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis | Q34227701 | ||
| Intussusception among infants given an oral rotavirus vaccine | Q34513591 | ||
| Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States | Q36235204 | ||
| Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil | Q37889979 | ||
| Changing epidemiology of intussusception in Australia | Q40390711 | ||
| Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine | Q40489497 | ||
| Indirect protection of adults from rotavirus by pediatric rotavirus vaccination | Q42277570 | ||
| Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience | Q43534254 | ||
| All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009. | Q43858536 | ||
| Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009. | Q44537751 | ||
| Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants | Q45306314 | ||
| Decline in Rotavirus Hospitalizations and Health Care Visits for Childhood Diarrhea Following Rotavirus Vaccination in El Salvador | Q45339666 | ||
| Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium | Q45400488 | ||
| Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception | Q46790602 | ||
| Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. | Q50936943 | ||
| Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme. | Q51157393 | ||
| Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia | Q56638996 | ||
| Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis | Q56995254 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| rotavirus vaccine | Q4411598 | ||
| disease prevention | Q106807541 | ||
| P304 | page(s) | 1427-1434 | |
| P577 | publication date | 2013-08-26 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program | |
| P478 | volume | 57 |
| Q47116624 | A benefit-risk analysis of rotavirus vaccination, France, 2015. |
| Q92244170 | A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine |
| Q37715611 | A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins |
| Q38172268 | Active surveillance for adverse events following immunization |
| Q61918194 | Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India |
| Q36242667 | Adversomics: a new paradigm for vaccine safety and design |
| Q40719231 | Age at First Rotavirus Vaccination and Risk of Intussusception in Infants: A Public Health Modeling Analysis |
| Q38648063 | An approach to death as an adverse event following immunization |
| Q35908214 | Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012) |
| Q37713784 | Assessing the risk of intussusception and rotavirus vaccine safety in Canada |
| Q96586351 | Assessment of risk of intussusception after pilot rollout of rotavirus vaccine in the Indian public health system |
| Q90481177 | Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants: A Systematic Review and Meta-analysis |
| Q55348211 | Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis. |
| Q31146806 | Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. |
| Q47114879 | Changes in the numbers of patients with acute gastroenteritis after voluntary introduction of the rotavirus vaccine in a Japanese children's primary emergency medical center |
| Q41546108 | Conquering rotavirus: from discovery to global vaccine implementation |
| Q92743228 | Countering vaccine hesitancy through immunization information systems, a narrative review |
| Q91878464 | Current and new rotavirus vaccines |
| Q38174842 | Diagnosis, management, and prevention of rotavirus gastroenteritis in children |
| Q90429655 | Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy |
| Q102319163 | Economic evaluation of the introduction of rotavirus vaccine in Hong Kong |
| Q45260893 | Editorial commentary: intussusception and rotavirus vaccination--balancing risk against benefit |
| Q38176032 | Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. |
| Q49955396 | Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial |
| Q36249319 | Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. |
| Q48529071 | Epidemiology of childhood intussusception in Bangladesh: Findings from an active national hospital based surveillance system, 2012-2016. |
| Q57945728 | Epidemiology of intussusception before and after rotavirus vaccine introduction in Fiji |
| Q64129959 | Epidemiology study of pediatric primary intussusception aged ≤24 months in pre-rotavirus vaccine era of Jinan, China |
| Q38947795 | Evaluating the potential risks and benefits of infant rotavirus vaccination in England. |
| Q92267944 | Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa |
| Q35947992 | Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants |
| Q41637575 | Febrile seizures following measles and varicella vaccines in young children in Australia. |
| Q55405177 | Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine. |
| Q36192146 | Immunisation timeliness in a cohort of urban Aboriginal and Torres Strait Islander children |
| Q97565448 | Impact of rotavirus vaccination on intussusception hospital admissions in England |
| Q92338476 | Impact of rotavirus vaccine on paediatric rotavirus hospitalisation and intussusception in New Zealand: A retrospective cohort study |
| Q39036974 | Incidence of acute intussusception among infants in eastern France: results of the EPIstudy trial |
| Q27024768 | Insights from global data for use of rotavirus vaccines in India |
| Q41050653 | Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014. |
| Q93126707 | Intussusception among Norwegian children: What to expect after introduction of rotavirus vaccination? |
| Q98183611 | Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants |
| Q35896246 | Intussusception following rotavirus vaccination in the Valencia Region, Spain |
| Q38234440 | Intussusception following rotavirus vaccination: an updated review of the available evidence |
| Q44246038 | Intussusception in southern India: comparison of retrospective analysis and active surveillance |
| Q30884781 | Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach. |
| Q38714154 | Intussusception-related Hospitalizations among Infants before and after Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013. |
| Q90677571 | Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules |
| Q31032101 | National hospital data for intussusception: Data linkage and retrospective analysis to assess quality and use in vaccine safety surveillance. |
| Q38255552 | New approaches in oral rotavirus vaccines |
| Q37130178 | Perspectives on benefit-risk decision-making in vaccinology: Conference report |
| Q64125113 | Polio endgame: Lessons for the global rotavirus vaccination program |
| Q38241735 | Population access to rotavirus vaccination in industrialized countries: lessons learnt from current experience |
| Q36568632 | Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis |
| Q36531176 | Post-marketing monitoring of intussusception after rotavirus vaccination in Japan. |
| Q37264988 | Post-rotavirus vaccine intussusception in identical twins: A case report |
| Q40693674 | Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines |
| Q47422424 | Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal. |
| Q91975985 | Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review |
| Q94420965 | Recommandations sur l’utilisation du vaccin antirotavirus chez les nourrissons |
| Q87889452 | Recommendations for the use of rotavirus vaccines in infants |
| Q37598089 | Rectal Bleeding and Abdominal Pain Following Vaccination in a 4-Month-Old Infant. |
| Q37723321 | Relationship between Pentavalent Rotavirus Vaccine and Intussusception: A Retrospective Study at a Single Center in Korea |
| Q48167285 | Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC). |
| Q38970217 | Review of Naturally Occurring Intussusception in Young Children in the WHO African Region prior to the Era of Rotavirus Vaccine Utilization in the Expanded Programme of Immunization |
| Q33654119 | Risk of Intussusception After Rotavirus Vaccination |
| Q48348851 | Risk of Intussusception with Rotavirus Vaccine. |
| Q99710176 | Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis |
| Q38709951 | Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohort and case-control studies |
| Q38994750 | Rotavirus Vaccination in India - Need for Surveillance of Intussusception |
| Q47547296 | Rotavirus Vaccines: Effectiveness, Safety, and Future Directions |
| Q51829359 | Rotavirus disease and vaccines in India: a tremendous public health opportunity. |
| Q37375904 | Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries |
| Q90501006 | Rotavirus vaccination and short-term risk of adverse events in US infants |
| Q47119066 | Rotavirus vaccines--balancing intussusception risks and health benefits |
| Q38795738 | Rotavirus vaccines: current global impact and future perspectives |
| Q45326050 | Rotavirus virus-like particles (RV-VLPs) vaccines: An update |
| Q26996393 | Rotaviruses |
| Q40141433 | Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial |
| Q37619157 | Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis |
| Q39693124 | The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation |
| Q92829469 | Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study |
| Q54212692 | Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage. |
| Q54550992 | Use of rotavirus vaccines in preterm babies on the neonatal unit. |
| Q37622789 | Vaccination ecosystem health check: achieving impact today and sustainability for tomorrow |
| Q64117280 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
| Q30977508 | Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines |
| Q59356442 | Viral gastroenteritis |
Search more.